Interoception in Anorexia Nervosa

NCT ID: NCT04981626

Last Updated: 2022-07-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-02-14

Study Completion Date

2023-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Anorexia nervosa is a serious psychiatric illness whose causes remain poorly understood, and which remains difficult to treat to this day. Many clinical manifestations of this disease can have their origin in abnormalities in the perception of signals coming from inside the body, but this remains to be demonstrated. In recent years, research in healthy subjects has shown how the brain constantly perceives the viscera (heart, lungs, stomach). The examiners will use these new, objective and validated methods to explore how the brain processes information from the viscera (interoception) in anorexic patients. In practice, they will quantify the coupling between the cardiac cycle and involuntary eye movements, as well as between the respiratory cycle and voluntary actions such as pressing a button. Finally, by simultaneously recording the electrical activity of the brain, and that of the stomach, the examiners will measure the coupling between the brain and the stomach. All these measurements, which will be compared between a population of patients and healthy subjects, will make it possible to determine whether anorexic patients have an alteration in the perception of their internal body signals and whether this damage affects several organs.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anorexia Anorexia Nervosa Electrocardiogram EEG

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

* Females
* Age : matched for the AN group
* No present or past eating disorders
* No past or current psychotic disorders
* No current substance abuse or dependence.
* No current psychiatric medication

Clinical and experimental session

Intervention Type OTHER

Psychologic profile with standardized interview and scales (see below for details: SCID, BDI, STAI, BPQ, EDE Q, Pictorial Body Image Scale (PBIS) and EDI).

Measure the stomach-brain synchrony during EEG/EGG resting state, the distribution of voluntary actions across the respiratory phase, and the distribution of saccadic eye movements across the cardiac-cycle.

AN group

* Females
* 16 years ≤ Age ≤ 25 years
* Diagnostic of AN according to DSM-5 criteria
* No past or current psychotic disorders
* No current substance abuse or dependence (excluding tobacco).
* No current psychiatric medication

Clinical and experimental session

Intervention Type OTHER

Psychologic profile with standardized interview and scales (see below for details: SCID, BDI, STAI, BPQ, EDE Q, Pictorial Body Image Scale (PBIS) and EDI).

Measure the stomach-brain synchrony during EEG/EGG resting state, the distribution of voluntary actions across the respiratory phase, and the distribution of saccadic eye movements across the cardiac-cycle.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Clinical and experimental session

Psychologic profile with standardized interview and scales (see below for details: SCID, BDI, STAI, BPQ, EDE Q, Pictorial Body Image Scale (PBIS) and EDI).

Measure the stomach-brain synchrony during EEG/EGG resting state, the distribution of voluntary actions across the respiratory phase, and the distribution of saccadic eye movements across the cardiac-cycle.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Females
* 6 to 25 years old
* Diagnostic of AN according to DSM-5 criteria
* No past or current psychotic disorders
* No current substance abuse or dependence (excluding tobacco).
* No current psychiatric medication


* Females
* Age : matched for the AN group
* No present or past eating disorders
* No past or current psychotic disorders
* No current substance abuse or dependence.
* No current psychiatric medication

Exclusion Criteria

* age below 16 years and above 25 years,
* Past or current psychotic disorders,
* Current substance abuse or dependence (excluding tobacco)
* Opposition to participation has been expressed.

In addition, for the control group,

* Subjects with present or past eating disorders or current mental disorders will be excluded.
Minimum Eligible Age

16 Years

Maximum Eligible Age

25 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Laboratoire de Psychologie et NeuroCognition

OTHER

Sponsor Role collaborator

University Hospital, Geneva

OTHER

Sponsor Role collaborator

Fondation Santé des Étudiants de France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marco Solca, Dr

Role: PRINCIPAL_INVESTIGATOR

ENS

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

ENS

Paris, Île-de-France Region, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nathalie Godart, PU-PH

Role: CONTACT

0145894339

Marco Solca, Dr

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marco Solca, DR

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-A00811-40

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.